Etiometry Closes the Gap in ARDS/PARDS Detection
News and Press Releases
In the winter issue of Respiratory Therapy, Jo’el Barr, Clinical Development Specialist at Etiometry, shares insights on the deployment of our PARDS pathway in two top U.S. children’s hospitals. The article highlights how Etiometry’s technology is empowering clinicians to recognize and manage Pediatric ARDS more effectively, driving better outcomes for critically ill children.
Related
PAS 2026 Abstract Reports Association Between IVCO2 Index Implementation and Blood Gas Measurement Frequency in NICU Patients
Boston, Mass., April 27, 2026 – Etiometry announced that a retrospective analysis was presented at the Pediatric Academic Societies (PAS) 2026 Meeting, evaluating changes in blood gas measurement frequency following clinical adoption of its IVCO2 Index in a Level IV Neonatal Intensive Care Unit (NICU). Investigators compared outcomes before and after implementation and reported 10% […]
First FDA-Cleared System Provides Real-Time Data for Cardiogenic Shock
Etiometry was recently featured in a Medscape interview with insights from our co-founder and CTO, Dimitar Baronov, alongside clinicians Walter Schiffer, MD, Cardiologist at Washington University School of Medicine and Srihari Naidu, MD, President of SCAI. The article highlights the importance of early identification in cardiogenic shock and how integrating continuous physiologic data with EHR, […]
Etiometry has been named one of the “Top Most Influential Companies to Watch 2026” by BizTech Outlook.
With recent FDA clearance for the first and only Hospital-Specific Cardiogenic Shock Classification and Tracking tool, we’re expanding how care teams can identify risk earlier and intervene with greater precision. The article highlights how critical care is evolving, using continuous data to help clinicians spot changes sooner and make more informed decisions at the bedside. […]